Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.58 USD
Change Today +0.19 / 2.26%
Volume 944.3K
INO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Niranjan Y. Sardesai Ph.D.

Chief Operating Officer, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

46$1,158,041
As of Fiscal Year 2014

Background*

Dr. Niranjan Y. Sardesai, PhD has been the Chief Operating Officer of Inovio Pharmaceuticals, Inc. since January 2012. Dr. Sardesai served as a Senior Vice President of Research & Development at Inovio Biomedical Corporation. from June 1, 2009 to December 2011. Dr. Sardesai served as Senior Vice President of Research & Development of VGX Pharmaceuticals, LLC from November 2007 to June 1, 2009. Dr. Sardesai served as Vice President of Product Development at VGX Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

660 West Germantown Pike
Plymouth Meeting, Pennsylvania 19462

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
California Institute of Technology
MBA
University of Pennsylvania - The Wharton School
MS
IIT Council
BS
Indian Institute of Technology, Bombay

Other Affiliations*

Annual Compensation*

Salary$348,940
Bonus$137,901
Total Annual Compensation$486,841

Stock Options*

All Other Compensation$11,325
Exercisable Options217,340
Unexercisable Options93,752
Total Number of Options311,092

Total Compensation*

Total Annual Cash Compensation$498,166
Total Short Term Compensation$486,841
Other Long Term Compensation$11,325
Total Calculated Compensation$1,158,041
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $8.58 USD +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$821.0K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$515.0K
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.